To #5, gainesville FL investigate the pharmacokinetics (PK) of three generic steroid-based dry powder inhaler (DPI) products in healthy subjects.

Ended Awarded Last action

Contract number
HHSF22301005T
Awardee
Awarding agency
Obligated
$7,265

Award facts

Opportunity
  • FDASOL1185780 Solicitation number
Contract value 100% obligated
$7,264.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Labor Hours
Place of performance
Gainesville, FL 32601, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$10,970
Original award $18,235

Quick answers

Who was awarded contract HHSF22301005T?

HHSF22301005T was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on February 20, 2018.

How much is contract HHSF22301005T worth?

The government has obligated $7,265 on HHSF22301005T.

Is contract HHSF22301005T an order under another contract?

Yes. HHSF22301005T is a delivery order under HHSF223201710031I, an indefinite delivery contract.

Was contract HHSF22301005T competed?

The extent of competition for HHSF22301005T was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award